Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sands Capital Ventures is a venture capital and private equity firm specializing in early-stage and growth investments across technology, healthcare (including biotech and pharma), financial services, and consumer sectors. It is particularly active in the life sciences, supporting companies developing therapeutics, diagnostics, and life sciences tools from early venture to post-IPO stages. The firm is known for crossover investments in companies preparing to go public, including notable biotech firms like Karuna Therapeutics, Dice Therapeutics, and Acrovon Therapeutics. Sands Capital Ventures does not develop its own therapeutics or diagnostics but instead partners with and funds innovative companies in these fields. The firm is recognized for its ability to support companies through multiple funding rounds, including growth equity and public market transactions, and for having a global investment reach.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sands Capital Ventures.